Sophie Lotersztajn,Fatima Teixeira-Clerc,Arlane Mallat,Alexandre Louvet
申请号：
US13384802
公开号：
US20120277296A1
申请日:
2010.07.21
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to selective CB2 agonists for use in the prevention or treatment of alcoholic liver disease and particularly alcoholic hepatic steatosis and liver inflammation, and pharmaceutical composition thereof.
